Up to €37.5m investment from the EIB, consisting of €10m upfront with optionality to further increase by an additional €27.5m €10m investment from existing shareholders including EQT Life Sciences (EQT) and Invest-NL Follows the announcement of excellent EU pivotal trial data highlighting...
Hence then, the article about xeltis secures nearly 50m from the european investment bank eib and existing shareholders to advance axess its vascular access conduit to the market was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Xeltis secures nearly €50m from the European Investment Bank (EIB) and existing shareholders to advance aXess, its vascular access conduit to the market )
Also on site :
- Watch Sheryl Crow Surprise Fans With New ‘Cars’ Song ‘Built to Last’ Ahead of Spin-Off Disney Jr. Series
- Iran, the economy and mending fences: Top takeaways from Trump interview with friend-turned-foe Michael Cohen
- Chris Hansen Was Turned Away From ‘Primetime’ Screening After Refusing To Sign Standard NDA, Not “Sign Away” His Rights